Variable | Wild-type | Single mutation | Multiple mutations | P-value |
---|---|---|---|---|
N = 177 | N = 39 | N = 7 | ||
Gender, N, (%) | ||||
Male | 145 (82%) | 31 (79%) | 6 (86%) | < 0.001 |
Female | 32 (18%) | 8 (21%) | 1 (14%) | |
Age, years, (IQR) | 70 (64–76) | 74 (68–78) | 65 (64–73) | 0.022 |
HBV or HCV, N, (%) | ||||
HCV | 53 (30%) | 11 (28%) | 5 (71%) | < 0.001 |
HBV | 34 (19%) | 8 (21%) | 0 (0%) | |
NBNC | 90 (51%) | 20 (51%) | 2 (29%) | |
ICG-R15, %, (IQR) | 9.5 (6.1–13.7) | 10.7 (7.5–15.7) | 13.4 (5.9–15.1) | 0.445 |
AFP, ng/ml, (IQR) | 9.2 (3.7–144.1) | 5.2 (2.3–24.2) | 641.4 (7.4–883.7) | 0.107 |
PIVKAII, mAU/ml, (IQR) | 116.0 (32.6–1495.0) | 414.0 (24.8–3537.5) | 5670.0 (160.0–37,800.0) | 0.032 |
Tumor size, mm, (IQR) | 35 (22–65) | 36 (25–76) | 63 (33–78) | |
Macrovascular invasion, N, (%) | ||||
Positive | 12 (7%) | 1 (3%) | 2 (29%) | 0.041 |
Microvascular invasion, N, (%) | ||||
Positive | 58 (33%) | 15 (38%) | 2 (29%) | 0.761 |